Authors


Timir K. Paul, MD, PhD

Latest:

COVID-19 Vaccine Hesitancy and Health Literacy in US Southern States

COVID-19 vaccine hesitancy is not associated with health literacy. Personal perception of threat was associated with reduced vaccine hesitancy.



Hamlet Gasoyan, PhD

Latest:

Improve Antiobesity Medication Adherence to Improve Results: Hamlet Gasoyan, PhD

Conversations between the patient and provider should focus on the stakes of antiobesity treatment and continuation, says Hamlet Gasoyan, PhD, Cleveland Clinic.


Susan R. Kirsh, MD, MPH

Latest:

Enhancing the e-Consult: Empowering Efficient and Collaborative Care

This editorial provides suggestions for improving the process of e-consults, which are a promising method of expanding access to specialty care.


Jeffrey Botbyl, MS

Latest:

Predicting Drug-Drug and Drug-Gene Interactions in a Community Pharmacy Population

The probability of drug interactions increases when genetic polymorphisms are considered, indicating that pharmacogenetic assessment may be useful in predicting the presence and severity of interactions.


Cameron Adams, MPP

Latest:

Patient Assignment and Quality Performance: A Misaligned System

This article explores the congruence between payer patient assignment and quality performance and the implications for incentive payments in alternative payment models.


Andrew W. Roberts, PharmD, PhD

Latest:

Trends in Medicare Part D Coverage of Generics With Equivalent Brand-Name Drugs

High-tier generic drug placement in Medicare Part D has increased over time, but it may be related to a drug’s clinical profile and availability of substitutes rather than preferred brand-name drug coverage.


Yueming Zhao, MPH

Latest:

Spending Patterns Among Commercially Insured Individuals During the COVID-19 Pandemic

In this analysis of more than 97 million commercially insured individuals, investigators found that the COVID-19 pandemic induced a spending shock in 2020 and that health care spending did not recover to baseline until mid-2021.


Anna Bobb, MPH

Latest:

Why Collaborative Care Is the Path Forward for Mental Health Care: Anna Bobb, MPH

Explore how the Collaborative Care Model enhances mental health access in this episode featuring Anna Bobb, MPH, executive director of the Path Forward coalition.


Dr María Díez Campelo | Image Credit: CCO
María Díez Campelo, MD, PhD

Latest:

Quality of Life, Caregiver Impact Key to Future Imetelstat Research in Lower-Risk MDS: María Díez Campelo, MD, PhD

María Díez Campelo, MD, PhD, concludes by highlighting imetelstat’s real-world quality of life benefits for patients with lower-risk myelodysplastic syndromes (MDS) and the need for improved patient-reported outcome tools and caregiver-focused research.


Oranus Mohammadi, MD

Latest:

The Expanding Role of Antibody-Drug Conjugates in Breast Cancer Treatment: Oranus Mohammadi, MD

Oranus Mohammadi, MD, outlines how antibody-drug conjugates are transforming breast cancer treatment across subtypes and discusses her approach to sequencing high-cost targeted therapies within payer and clinical practice constraints.


Keith A. Horvath, MD

Latest:

What Value Do Teaching Hospitals Provide Commercial Beneficiaries When in an ACO?

Accountable care organizations (ACOs) with a major teaching hospital were associated with lower mortality, lower inpatient spending, lower emergency department utilization, and higher overall outpatient spending.


Jarrod E. Dalton, PhD

Latest:

High-Intensity Home-Based Rehabilitation in a Medicare Accountable Care Organization

High-intensity home-based rehabilitation (HIHR) may substitute for facility-based postacute rehabilitation. Patients in HIHR had better functional outcomes at lower costs than patients in facility-based care.


Charles C. Wykoff, MD, PhD

Latest:

Future Research Directions for Revakinagene Taroretcel in MacTel

Charles C. Wykoff, MD, PhD, Retinal Consultants of Texas, spoke to the current state of research on revakinagene taroretcel in macular telangiectasia type 2 (MacTel), as well as the importance of patient groups for the rare condition.


Michael R. Richards, MD, PhD, MPH

Latest:

Removing Medicare’s Outpatient Ban and Medicare and Private Surgical Trends

This article documents a 100% increase in privately insured outpatient knee replacement surgeries following Medicare’s decision to remove knee replacements from its Inpatient Only list.


Blair Burnett, BA

Latest:

Considerations to Increase Rates of Breast Cancer Screening Across Populations

Authors from the Community Oncology Alliance and Avalere Health present data that show breast cancer screening rates recovered more slowly among some racial/ethnic groups following on the onset of the COVID-19 pandemic.


Adam Matsil, MS

Latest:

Primary Care Visit Cadence and Hospital Admissions in High-Risk Patients

Patients with congestive heart failure and/or chronic obstructive pulmonary disease who had more quarterly primary care visits had lower rates of hospitalizations during the COVID-19 pandemic.


Joyce Wang

Latest:

Contributor: Providers and Patients Push Back, Payers Push Forward—Co-pay Mitigation Programs

Research shows how commercial health plans impact payer trends in the co-pay landscape and provides key areas that pharmaceutical and biotech manufacturers can explore to ensure patient access.



Kate Estep

Latest:

AI-Driven Clinical Support Tools Show Promise in Alleviating Provider Burnout and Workflow Challenges

Stephen Speicher, MD, and Kate Estep, from Flatiron Health, discuss the future of oncology care with artificial intelligence (AI).


Sourya Sourabh Mohakuda, MD

Latest:

Clinical Profile of COVID-19 Infection in Postvaccination Individuals

This article describes the findings of an observational study carried out in India to examine the clinical profile of individuals detected to be COVID-19 positive post vaccination.



Jean L. Raphael, MD

Latest:

TCD Screening and Spending Among Children With Sickle Cell Anemia

A substantial proportion of families of privately insured children with sickle cell anemia pay more than $100 for essential stroke screenings, a high-value service.


Scott A. Soefje, PharmD

Latest:

Neulasta Onpro: A Coup de Grâce?

With the rapid decline in average sales price of reference pegfilgrastim products due to biosimilar competition, health care institutions and payers may grapple with coverage of Neulasta Onpro.


Rita Assi, MD

Latest:

Final Words: Aligning Innovation, Guidelines, and Access

Panelists expressed cautious optimism about high-risk acute myeloid leukemia (AML) treatment, emphasizing the need for ongoing research, personalized therapy based on molecular profiling, and strengthened collaboration between community and academic centers to improve patient outcomes, while recognizing that education and sharing best practices are key to advancing targeted therapies and achieving long-term cures.



Alexa N. Fiffick, DO, MBS, MSCP

Latest:

Closing Thoughts: Evolving Treatment Paradigms in Menopause Management

Panelists express their gratitude for the informative discussion and share their final thoughts on the evolving landscape of menopause management and the potential impact of new therapies on improving patient outcomes.


Mark Stephens, MD

Latest:

Mobile Health Clinic: Lessons Learned Building Partnerships Across Health Systems

Establishing mobile health clinics in rural settings requires collaboration across health systems by aligning missions, building infrastructure to support research, and demonstrating proof of concept.


Vannessa Harrison, DrPH

Latest:

Hospital Discharge Diagnosis Position: Impact on Adult Pneumonia Burden Estimates

Disease burden estimates of pneumonia-associated hospitalizations are more sensitive when including pneumonia coded in any diagnosis field vs in only the first discharge diagnosis field.


Edward Juhn, MD, MBA, MPH

Latest:

Contributor: Beyond a One-Size-Fits-All for Managed Care Plan Benchmarks

Comparing plans with similar characteristics, such as size, geographic location, or demographics served, allows for more meaningful insights and improvement opportunities.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo